Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Electronic prescribing of controlled substances among office-based physicians: 2017-2019
Electronic prescribing of controlled substances among office-based physicians: 2017-2019
Electronic prescribing of controlled substances (EPCS) technology enables clinicians to securely transmit prescriptions for controlled substances to a pharmacy. In 2018, the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) mandated the prescribing of Schedule II, III, IV, or V controlled substances under Medicare Part D to be done using EPCS technology starting January 1, 2021. This mandate was implemented and finalized through the Centers for Medicare & Medicaid Services (CMS) Calendar Year (CY) 2021 Physician Fee Schedule specifying appropriate exceptions and providing compliance flexibilities through January 1, 2022. This brief provides national estimates of physicians’ use of EPCS technology in 2019 from the National Electronic Health Record Survey. These findings serve as baseline estimates upon which to examine the future impact of the Part D EPCS mandate going into effect. The brief also explores variation in the use of EPCS by physician characteristics, including practice size and ownership, physician specialty, geographic location, and frequency of a physician prescribing controlled substances.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)